- Home
- ZVIA vs TVGN Comparison
ZVIA vs TVGN Comparison
Compare ZVIA & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVIA
- TVGN
- Stock Information
- Founded
- ZVIA 2007
- TVGN 2020
- Country
- ZVIA United States
- TVGN United States
- Employees
- ZVIA N/A
- TVGN N/A
- Industry
- ZVIA Beverages (Production/Distribution)
- TVGN Blank Checks
- Sector
- ZVIA Consumer Staples
- TVGN Finance
- Exchange
- ZVIA Nasdaq
- TVGN Nasdaq
- Market Cap
- ZVIA 196.2M
- TVGN 193.1M
- IPO Year
- ZVIA 2021
- TVGN N/A
- Fundamental
- Price
- ZVIA $3.29
- TVGN $1.06
- Analyst Decision
- ZVIA Hold
- TVGN Strong Buy
- Analyst Count
- ZVIA 2
- TVGN 1
- Target Price
- ZVIA $3.38
- TVGN $10.00
- AVG Volume (30 Days)
- ZVIA 1.0M
- TVGN 645.6K
- Earning Date
- ZVIA 08-06-2025
- TVGN 08-13-2025
- Dividend Yield
- ZVIA N/A
- TVGN N/A
- EPS Growth
- ZVIA N/A
- TVGN N/A
- EPS
- ZVIA N/A
- TVGN N/A
- Revenue
- ZVIA $154,273,000.00
- TVGN N/A
- Revenue This Year
- ZVIA $5.70
- TVGN N/A
- Revenue Next Year
- ZVIA $6.76
- TVGN N/A
- P/E Ratio
- ZVIA N/A
- TVGN N/A
- Revenue Growth
- ZVIA N/A
- TVGN N/A
- 52 Week Low
- ZVIA $0.76
- TVGN $0.26
- 52 Week High
- ZVIA $4.99
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- ZVIA 57.29
- TVGN 36.03
- Support Level
- ZVIA $2.60
- TVGN $1.18
- Resistance Level
- ZVIA $3.46
- TVGN $1.42
- Average True Range (ATR)
- ZVIA 0.20
- TVGN 0.07
- MACD
- ZVIA 0.03
- TVGN -0.02
- Stochastic Oscillator
- ZVIA 79.65
- TVGN 5.26
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.